GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 50 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EAFG | GSK | |
---|---|---|
RSI ODDS (%) | 2 days ago67% | 2 days ago50% |
Stochastic ODDS (%) | 2 days ago86% | 2 days ago55% |
Momentum ODDS (%) | 2 days ago59% | 2 days ago74% |
MACD ODDS (%) | 2 days ago83% | 2 days ago41% |
TrendWeek ODDS (%) | 2 days ago76% | 2 days ago61% |
TrendMonth ODDS (%) | 2 days ago69% | 2 days ago54% |
Advances ODDS (%) | 16 days ago79% | 5 days ago59% |
Declines ODDS (%) | N/A | 3 days ago51% |
BollingerBands ODDS (%) | 2 days ago86% | 2 days ago43% |
Aroon ODDS (%) | 2 days ago73% | 2 days ago46% |
A.I.dvisor tells us that EAFG and ROG have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAFG and ROG's prices will move in lockstep.
Ticker / NAME | Correlation To EAFG | 1D Price Change % | ||
---|---|---|---|---|
EAFG | 100% | -0.83% | ||
ROG - EAFG | 19% Poorly correlated | -1.51% | ||
GSK - EAFG | 18% Poorly correlated | +0.32% | ||
EVO - EAFG | 17% Poorly correlated | -3.00% | ||
AZN - EAFG | 15% Poorly correlated | +1.03% | ||
GMAB - EAFG | 12% Poorly correlated | +1.28% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.